REAL-WORLD DATA FROM PATIENTS WITH SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION: AN ANALYSIS OF ANTITHROMBIN SUPPLEMENTATION POST-MARKETING SURVEILLANCE DATA

被引：0
|
作者：
Eguchi, Yutaka
机构：
来源：
SHOCK | 2024年 / 62卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
4080197
引用
收藏
页码：38 / 39
页数：2
相关论文
共 50 条
  • [31] Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China
    Li, Jin
    Li, Meijun
    Li, Liren
    Ma, Lin
    Cao, Ailin
    Wen, Aiping
    Chen, Wenge
    Li, Lingling
    Liang, Yan
    Deng, Jianxiong
    BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01):
  • [32] Real-world effectiveness of eculizumab in generalized myasthenia gravis in Japan: 1-year post-marketing surveillance data
    Murai, Hiroyuki
    Suzuki, Shigeaki
    Fukamizu, Yuji
    Osawa, Takehiko
    Kikui, Hidekazu
    Utsugisawa, Kimiaki
    NEUROLOGY, 2022, 98 (18)
  • [33] Real-world safety of the novel, free radical scavenger edaravone for amyotrophic lateral sclerosis patients: Data from the post-marketing surveillance SUNRISE Japan
    Ishizaki, Kaoru
    Yoshimura, Kenta
    Yoshida, Kengo
    Matsuda, Masao
    Kawaguchi, Yutaka
    Yuki, Satoshi
    Sobue, Gen
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2021, 9 (03): : 223 - 229
  • [34] Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data
    Chen, Gang
    Ning, Li-Juan
    Qin, Yan
    Zhao, Bin
    Mei, Dan
    Li, Xue-Mei
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (01) : 156 - 162
  • [35] Real-world safety of ulinastatin: a post-marketing surveillance of 11,252 patients in China
    Jin Li
    Meijun Li
    Liren Li
    Lin Ma
    Ailin Cao
    Aiping Wen
    Wenge Chen
    Lingling Li
    Yan Liang
    Jianxiong Deng
    BMC Pharmacology and Toxicology, 23
  • [36] APPLICATION OF REAL-WORLD DATA FROM MEDICAL BIG-DATA PLATFORM IN REAL WORLD EVIDENCE GENERATION: A PRACTICE IN POST-MARKETING RESEARCH IN CHINA
    Wang, Y.
    Xing, Y.
    Wu, Y.
    Yuan, N.
    Wang, F.
    Jiang, B.
    Xiong, T.
    VALUE IN HEALTH, 2020, 23 : S256 - S256
  • [37] Real-world safety of nusinersen in Japan: results from an interim analysis of a post-marketing surveillance and safety database
    Wataya, Takafumi
    Takasaki, Sakura
    Hoshino, Misuzu
    Makioka, Haruki
    Nakamura, Genshu
    Matsuda, Naoto
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (08) : 851 - 863
  • [38] Hypoglycemia following the use of glucagon-like peptide-1 receptor agonists: a real-world analysis of post-marketing surveillance data
    Zhao, Zhe
    Tang, Yan
    Hu, Yang
    Zhu, Huijuan
    Chen, Xiaoguang
    Zhao, Bin
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
  • [39] A Post-Marketing Drug Evaluation Framework Based on Real-World Electronic Health Records Data
    Wang, Yu
    Ma, Shuang
    Ru, Hua
    Ni, Hongyi
    Li, Jingsong
    MEDINFO 2023 - THE FUTURE IS ACCESSIBLE, 2024, 310 : 134 - 138
  • [40] Real-world safety and effectiveness of rotigotine in patients with Parkinson's disease: analysis of a post-marketing surveillance study in Japan
    Ito, Hidefumi
    Takayama, Tomoyo
    Kondo, Hiroyuki
    Fukuta, Yasuhiko
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2022, 132 (03) : 237 - 247
12345